Page last updated: 2024-10-24

calmidazolium and Chronic Illness

calmidazolium has been researched along with Chronic Illness in 1 studies

calmidazolium: powerful inhibitor of or red blood cell Ca++-ATPase & Ca++ transport into inside-out red blood cell vesicles; RN refers to chloride; structure in first source; an antagonist of calmodulin
calmidazolium : An imidazolium ion that is imidazolium cation substituted by a bis(4-chlorophenyl)methyl group at position 1 and a 2-[(2,4-dichlorobenzyl)oxy]-2-(2,4-dichlorophenyl)ethyl group at position 3. It acts as an antagonist of calmodulin, a calcium binding messenger protein.

Research Excerpts

ExcerptRelevanceReference
" Dose-response curves to phenylephrine (PE) 10(-9) to 5 x 10(-6) M) were examined in PA rings as well as response to L-arginine analogues in isolated lungs from CH or normoxic (N) rats after various incubation times."1.30Induction of nitric oxide synthase activity in pulmonary arteries from normoxic and chronically hypoxic rats. ( Adnot, S; Carville, C; Eddahibi, S; Raffestin, B; Rideau, D; Teiger, E, 1997)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Carville, C1
Adnot, S1
Eddahibi, S1
Teiger, E1
Rideau, D1
Raffestin, B1

Other Studies

1 other study available for calmidazolium and Chronic Illness

ArticleYear
Induction of nitric oxide synthase activity in pulmonary arteries from normoxic and chronically hypoxic rats.
    The European respiratory journal, 1997, Volume: 10, Issue:2

    Topics: Animals; Aorta; Chronic Disease; Dactinomycin; Dose-Response Relationship, Drug; Endothelium, Vascul

1997